| Ampelopsis megalophylla Diels et.Gilg is a medicincal plant of Ampelopsis. It is a herb commonly used in Enshi of Hubei province. It is neutral in nature and has sour and bitter tasting. The article studied on the anti-HBV effective parts and the anti-HBV effective constituents of Ampelopsis megalophylla,and the content of the effective constituent.Ethanol extract of Ampelopsis megalophylla (â… ) was dissolved in water and fracticnated sequentially with Petroleum ether and EtoAc. The fraction were concentrated to yield the Petroleum ether fraction(â…¡), EtoAc fraction (â…¢) and water fraction (â…£). The TC50 ofâ…¡,â…¢are 99.1μg/ml and 250μg/ml. The IC50 ofâ…¡to HBsAg and HBeAg are 4.2μg/ml and 26.3μg/ml, the TI are 23.6 and 3.8. The IC50 ofâ…¢to HBsAg and HBeAg are 16.7μg/ml and 62.5μg/ml, the TI are 14.9 and 4.0.We isolated and purified the chemical contituents in Petroleum ether fraction of Ampelopsis megalophylla. Silica gel column chro-matograph and sephadex LH-20 column chromatograph were used. As a result,4 compounds was isolated and identified. They are Chrysoph-anol, Physcion, Myricetin andβ-sitosterol. The compounds Chrys-ophanol and Physcion are isolated from this plant for the first time. The compounds Chrysophanol, Myricetin from the fractionâ…¡and Ampelopsin, myricetrin, Quercetin and Quercitrin from the fractionâ…¢were used to evaluate the anti-HBV activity in vitro. The Ampelopsin and Myricetin exhibit anti-HBV activity. The TC50 are 187.5μg/ml and 250μg/ml. The IC50 of HBsAg and HBeAg of Ampelopsin are 44.0μg/ml and 15.4μg/ml. The TI are 4.3 and 12.2. The IC50 of HBsAg and HBeAg of Myricetin are 59.3μg/ml and 12.2μg/ml. The TI are 4.2 and 20.5. Ampelopsin and Myricetin are the active compounds from the fractionâ…¡and the fractionâ…¢.HPLC was used to determine the content of Ampelopsin in Ampelop-sis megalophylla from different areas. The result indicated the content of Ampelopsin is about 30% in Ampelopsis megalophylla. This research shows the medicinal plant posseses a broad developing prospect. |